scholarly article | Q13442814 |
P356 | DOI | 10.1002/LT.23605 |
P698 | PubMed publication ID | 23447460 |
P50 | author | Kenneth Siu Ho Chok | Q43152097 |
P2093 | author name string | See Ching Chan | |
Ronnie T P Poon | |||
Tan To Cheung | |||
Chung Mau Lo | |||
Sheung Tat Fan | |||
Albert C Y Chan | |||
Dai Wing Chiu | |||
P2860 | cites work | A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma | Q24544663 |
Management of hepatocellular carcinoma: An update | Q27860530 | ||
Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation | Q33508431 | ||
Resection prior to liver transplantation for hepatocellular carcinoma | Q33974096 | ||
Repeat liver resection for hepatocellular carcinoma | Q34178967 | ||
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value | Q34290128 | ||
Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study | Q34551964 | ||
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma | Q37775714 | ||
Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma | Q38506199 | ||
Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma | Q39944217 | ||
Repeated liver resection for recurrent liver cancer | Q41116318 | ||
Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma | Q41881803 | ||
Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma | Q42631803 | ||
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis | Q42633082 | ||
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria | Q43484980 | ||
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. | Q43601180 | ||
Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. | Q43830759 | ||
Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. | Q44215717 | ||
Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening | Q44439106 | ||
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? | Q44590324 | ||
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis | Q44670527 | ||
Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center | Q44755695 | ||
Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma | Q45365588 | ||
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. | Q45958504 | ||
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database | Q46129535 | ||
Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation | Q47371856 | ||
Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma | Q47423426 | ||
Lessons learned from one hundred right lobe living donor liver transplants. | Q52088998 | ||
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. | Q53383343 | ||
Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk. | Q53521070 | ||
Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. | Q53597195 | ||
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. | Q54669466 | ||
Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation | Q56786296 | ||
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience | Q56992829 | ||
P433 | issue | 4 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
recurrent hepatocellular carcinoma | Q19000463 | ||
P304 | page(s) | 411-419 | |
P577 | publication date | 2013-03-17 | |
P1433 | published in | Liver Transplantation | Q15730498 |
P1476 | title | Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? | |
P478 | volume | 19 |
Q28392783 | 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma |
Q28394414 | 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma |
Q38337088 | Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors |
Q42378979 | Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas |
Q88581876 | Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation |
Q30364978 | Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma. |
Q92418088 | Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis |
Q50851803 | Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular Carcinoma. |
Q53088926 | Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. |
Q43093333 | Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells. |
Q53526985 | Early and resectable HCC: Definition and validation of a subgroup of patients who could avoid liver transplantation. |
Q42844232 | Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer. |
Q36570294 | Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis |
Q38168706 | Feasibility of laparoscopic re-resection for patients with recurrent hepatocellular carcinoma. |
Q36278929 | Finding Optimal Ablation Parameters for Multipolar Radiofrequency Ablation |
Q47146359 | Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells |
Q57788740 | Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma |
Q38163597 | Hepatocellular carcinoma and cholangiocarcinoma: an update |
Q35631295 | Hong Kong consensus recommendations on the management of hepatocellular carcinoma |
Q37333788 | Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan |
Q48302581 | Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study. |
Q90664420 | Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma |
Q50972218 | Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome. |
Q45970752 | Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation. |
Q64943233 | Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. |
Q48120794 | Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern |
Q41680018 | Patterns of cancer recurrence in localized resected hepatocellular carcinoma |
Q58564371 | Perioperative Outcomes of Laparoscopic Repeat Liver Resection for Recurrent HCC: Comparison with Open Repeat Liver Resection for Recurrent HCC and Laparoscopic Resection for Primary HCC |
Q28073769 | Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma |
Q51690868 | Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. |
Q41790928 | Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis. |
Q35469103 | Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection |
Q42224465 | Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma |
Q48293892 | Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis |
Q91854143 | Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling |
Q36359054 | Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria |
Q38933888 | Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence |
Q49670510 | Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation |
Q38769255 | Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration |
Q53578154 | Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation. |
Q38151787 | Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma |
Q64113089 | Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy |
Q51009835 | The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. |
Q41194963 | The role of liver transplantation or resection for patients with early hepatocellular carcinoma |
Q36072908 | The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo |
Q64232879 | Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma |
Q38549768 | Treatment of Liver Cancer |